It is therefore likely that no decision on the renewal of the approvals of all the active substances covered by this Regulation can be taken before the expiry of their respective approval periods, between 31 January and 30 April 2025. Furthermore, the reasons for the delays in these renewal procedures are beyond the control of the respective applicants. Therefore, the approval periods of those active substances should be extended in order to enable the completion of the assessments required and to finalise the respective procedures on the renewal of the approvals.
Recital 33, Regulation (EU) 2025/99
In forcesince 21 Jan 2025